Everolimus

Everolimus is a macrocyclic lactone that is rapamycin in which the hydroxy group attached to the cyclohexyl moiety has been converted into the corresponding 2-hydroxyethyl ether. It is an immunosuppressant and antineoplastic agent. Among its listed roles, it functions as a antineoplastic agent, an immunosuppressive agent, a mTOR inhibitor, an anticoronaviral agent and a geroprotector. It is a primary alcohol, a secondary alcohol, an ether, a cyclic ketone, a cyclic acetal and a macrolide lactam. Functionally, it is related to member of sirolimus. It is grouped under the following drug class(es): Immunosuppressants and Kinase inhibitors. Its therapeutic use is listed as anti-cancer agents, anti-epileptic drugs, antineoplastics and central nervous system (CNS) agents. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Zortress, Afinitor and Certican. Its PubChem CID is 6442177.